The overall aims are to understand the roles and activities of the epidermal growth factor receptor (EGFR) in developing embryos in vivo. Known effects of signalling after ligand binding to the EGFR range from changes in membrane motility, cell shape and epithelial polarity to the stimulation of proliferation or to increased differentiation. Over- expression of the EGFR gene in EC cells can lead to differentiation. In contrast, in non-embryonic cells, over-expression can lead to aberrant or transformed growth. Our understanding of how EGFR activities are modulated and how gene expression is regulated is still fragmentary. In the last grant period, we characterized the activities of a truncated, kinase- negative version of EGFR after transfection of the expression plasmid into Pl9 embryonal carcinoma (EC) cells. We showed that truncated EGFR acted as a dominant negative mutation, abrogating the activities of the normal EGF receptor. The result was inhibition of the process of differentiation to nervous tissues after induction by retinoic acid. The present proposal builds on and extends this approach. We propose to perturb the levels of EGFR in EC cells, embryonal stem (ES) cells and in embryos as an approach to understanding the roles of the EGFR in normal and aberrant growth.
The specific aims are:- l. To study the roles of the EGFR in ES cells and in transgenic mice by introducing a dominant negative mutation of the receptor. 2. To study the roles of EGFRs in vitro and in vivo by over- expression of human EGFRs with and without accompanying transforming growth factor alpha (TGFalpha) expression in EC and ES cells and in transgenic mice. 3. To make initial studies of the roles and regulation of EGFRs in ovarian cells and tumors. 4. To determine some of the components in the EGFR signal transduction pathway in preimplantation embryos using antibodies and RT-PCR. A number of hypotheses will be tested. For instance, that autocrine-stimulated EGF-Rs provide a driving force to the continuation of differentiation and its irreversibility and stability such that when aberrant, tumors are initiated or stimulated to progress.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA028427-13
Application #
2376758
Study Section
Human Embryology and Development Subcommittee 1 (HED)
Program Officer
Freeman, Colette S
Project Start
1980-07-01
Project End
1999-02-28
Budget Start
1997-03-18
Budget End
1999-02-28
Support Year
13
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Sanford-Burnham Medical Research Institute
Department
Type
DUNS #
009214214
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Niemeyer, C C; Spencer-Dene, B; Wu, J X et al. (1999) Preneoplastic mammary tumor markers: Cripto and Amphiregulin are overexpressed in hyperplastic stages of tumor progression in transgenic mice. Int J Cancer 81:588-91
Liu, C; Rangnekar, V M; Adamson, E et al. (1998) Suppression of growth and transformation and induction of apoptosis by EGR-1. Cancer Gene Ther 5:3-28
Xu, W; Coll, J L; Adamson, E D (1998) Rescue of the mutant phenotype by reexpression of full-length vinculin in null F9 cells;effects on cell locomotion by domain deleted vinculin. J Cell Sci 111 ( Pt 11):1535-44
Huang, R P; Fan, Y; deBelle, I et al. (1998) Egr-1 inhibits apoptosis during the UV response: correlation of cell survival with Egr-1 phosphorylation. Cell Death Differ 5:96-106
Xu, W; Baribault, H; Adamson, E D (1998) Vinculin knockout results in heart and brain defects during embryonic development. Development 125:327-37
Huang, R P; Fan, Y; de Belle, I et al. (1997) Decreased Egr-1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formation. Int J Cancer 72:102-9
Tsark, E C; Adamson, E D; Withers 3rd, G E et al. (1997) Expression and function of amphiregulin during murine preimplantation development. Mol Reprod Dev 47:271-83
Adamson, E D; Wiley, L M (1997) The EGFR gene family in embryonic cell activities. Curr Top Dev Biol 35:71-120
Wu, J X; Adamson, E D (1996) Kinase-negative mutant epidermal growth factor receptor (EGFR) expression during embryonal stem cell differentiation favours EGFR-independent lineages. Development 122:3331-42
Huang, R P; Wu, J X; Fan, Y et al. (1996) UV activates growth factor receptors via reactive oxygen intermediates. J Cell Biol 133:211-20

Showing the most recent 10 out of 29 publications